There are 412 resources available
Profiling of TME to unravel unresponsiveness to IO
Presenter: Giampaolo Bianchini
Session: Lessons from recent translational approaches
Resources:
Slides
Webcast
The medical oncologist: Systemic treatment after targeted approaches to the axilla
Presenter: Elisabetta Munzone
Session: Axillary management in the post-neoadjuvant setting: Local therapy, prognostic information and quality of life (QoL)
Resources:
Slides
Webcast
Other potential adjuvant strategies for high-risk HR+HER2- breast cancer
Presenter: Yoon Sim Yap
Session: New adjuvant strategies for luminal cancers
Resources:
Slides
Webcast
Conclusions and clinical perspectives
Session: Lessons from recent translational approaches
Resources:
Webcast
Quality of life after axillary surgery: Lymphedema and beyond
Presenter: Fiorita Poulakaki
Session: Axillary management in the post-neoadjuvant setting: Local therapy, prognostic information and quality of life (QoL)
Resources:
Slides
Webcast
Q&A and discussion
Session: New adjuvant strategies for luminal cancers
Resources:
Webcast
Q&A and discussion
Session: Axillary management in the post-neoadjuvant setting: Local therapy, prognostic information and quality of life (QoL)
Resources:
Webcast
Supportive care for treatment toxicity
Presenter: Andrew Neil Tippings Davies
Session: Actionable targets to improve survival experience
Resources:
Slides
Webcast
LBA2 - Datopotamab deruxtecan (Dato-DXd) vs chemotherapy (CT) in pretreated, inoperable/metastatic HR+/HER2– breast cancer (BC): Additional safety analysis from TROPION-Breast01
Presenter: Komal Jhaveri
Session: Proffered Paper session 2
Resources:
Abstract
Slides
Webcast
Q&A and discussion
Session: Proffered Paper session 2
Resources:
Webcast